Atovaquone

Generic: Atovaquone

Labeler: McKesson Corporation dba SKY Packaging
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive

Drug Facts

Product Profile

Brand Name Atovaquone
Generic Name Atovaquone
Labeler McKesson Corporation dba SKY Packaging
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

ATOVAQUONE 750 mg/5mL

Identifiers & Regulatory

Product NDC 63739-203
Product ID 63739-203_f94a1099-3e13-45b0-933c-65367ee36601
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214272
Marketing Start 2024-07-08
Marketing End 2026-02-28

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63739203
Hyphenated Format 63739-203

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name Atovaquone (source: ndc)
Generic Name Atovaquone (source: ndc)
Application Number ANDA214272 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 750 mg/5mL
source: ndc
Packaging
  • 5 mL in 1 CUP, UNIT-DOSE (63739-203-01)
  • 42 CUP, UNIT-DOSE in 1 CASE (63739-203-02) / 5 mL in 1 CUP, UNIT-DOSE (63739-203-01)
  • 18 CUP, UNIT-DOSE in 1 CASE (63739-203-03) / 5 mL in 1 CUP, UNIT-DOSE (63739-203-01)
source: ndc

Packages (3)

63739-203-01 5 mL in 1 CUP, UNIT-DOSE (63739-203-01) 63739-203-02 42 CUP, UNIT-DOSE in 1 CASE (63739-203-02) / 5 mL in 1 CUP, UNIT-DOSE (63739-203-01) 63739-203-03 18 CUP, UNIT-DOSE in 1 CASE (63739-203-03) / 5 mL in 1 CUP, UNIT-DOSE (63739-203-01)

Ingredients (1)

ATOVAQUONE (750 mg/5mL)

Linked Drug Pages (1)

Atovaquone ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f94a1099-3e13-45b0-933c-65367ee36601", "openfda": {"nui": ["N0000175482", "N0000175485"], "unii": ["Y883P1Z2LT"], "rxcui": ["308429"], "spl_set_id": ["e079b043-09bd-44c2-b42d-f7b35f8a08e5"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "manufacturer_name": ["McKesson Corporation dba SKY Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "5 mL in 1 CUP, UNIT-DOSE (63739-203-01)", "package_ndc": "63739-203-01", "marketing_end_date": "20260228", "marketing_start_date": "20240708"}, {"sample": false, "description": "42 CUP, UNIT-DOSE in 1 CASE (63739-203-02)  / 5 mL in 1 CUP, UNIT-DOSE (63739-203-01)", "package_ndc": "63739-203-02", "marketing_end_date": "20260228", "marketing_start_date": "20240708"}, {"sample": false, "description": "18 CUP, UNIT-DOSE in 1 CASE (63739-203-03)  / 5 mL in 1 CUP, UNIT-DOSE (63739-203-01)", "package_ndc": "63739-203-03", "marketing_end_date": "20260228", "marketing_start_date": "20240708"}], "brand_name": "Atovaquone", "product_id": "63739-203_f94a1099-3e13-45b0-933c-65367ee36601", "dosage_form": "SUSPENSION", "pharm_class": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "product_ndc": "63739-203", "generic_name": "Atovaquone", "labeler_name": "McKesson Corporation dba SKY Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atovaquone", "active_ingredients": [{"name": "ATOVAQUONE", "strength": "750 mg/5mL"}], "application_number": "ANDA214272", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20240708"}